The law offices of frank r. cruz continues its investigation of anavex life sciences corp. (avxl) on behalf of investors

Los angeles--(business wire)--the law offices of frank r. cruz continues its investigation of anavex life sciences corp. (“anavex” or the “company”) (nasdaq: avxl) on behalf of investors concerning the company's possible violations of federal securities laws. if you are a shareholder who suffered a loss, click here to participate. on february 1, 2022, before the market opened, anavex announced that a phase 3 trial of anavex2-73 (blarcamesine) for rett syndrome met primary and secondary endpoint
AVXL Ratings Summary
AVXL Quant Ranking